Gatta G. Capocaccia R. Botta L. et al.

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

Lancet Oncol. 18: 1022-1039Penel N. Grosjean J. Robin Y.M. et al.

Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases.

Sarcoma. 2008: 459386von Mehren M. Kane J.M. Bui M.M. et al.

NCCN guidelines insights: soft tissue sarcoma, version 1.2021.

J Natl Compr Canc Netw. 18: 1604-1612de Juan Ferré A. Álvarez Álvarez R. Casado Herráez A. et al.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020).

Clin Transl Oncol. 23: 922-930

The management of cancer in the older adolescent.

Eur J Cancer. 39: 2584-2599Geraci M. Birch J.M. Alston R.D. et al.

Cancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005.

Br J Cancer. 97: 1588-1594Voss R.K. Chiang Y.J. Torres K.E. et al.

Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.

Ann Surg Oncol. 24: 3271-3278Coindre J.M. Terrier P. Guillou L. et al.

Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group.

Cancer. 91: 1914-1926

NCIN Bone and soft tissue sarcomas. UK incidence and survival. 1996–2010. 2nd edn; 2013. p. 1–17. Available at: http://www.ncin.org.uk/cancer_type_and_topic_specific_work/cancer_type_specific_work/sarcomas/.

Kotilingam D. Lev D.C. Lazar A.J.F. et al.

Staging soft tissue sarcoma: evolution and change.

CA Cancer J Clin. 56 (): 282-291Dangoor A. Seddon B. Gerrand C. et al.

UK guidelines for the management of soft tissue sarcomas.

Clin Sarcoma Res. 6: 20Aparisi Gómez M.P. Errani C. Lalam R. et al.

The role of ultrasound in the diagnosis of soft tissue tumors.

Semin Musculoskelet Radiol. 24: 135-155Kumar V. Abbas A.K. Fausto N. et al.Robbins and cotran pathologic basis of disease. 7th edition. Elsevier Saunders, Amsterdam, The NetherlandsMurphey M.D. Arcara L.K. Fanburg-Smith J.

From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation.

Radiographics. 25: 1371-1395

Lipomas, lipoma variants, and well-differentiated liposarcomas (atypical lipomas): results of MRI evaluations of 126 consecutive fatty masses.

AJR Am J Roentgenol. 182: 733-739Grobmyer S.R. Brennan M.F.

Predictive variables detailing the recurrence rate of soft tissue sarcomas.

Curr Opin Oncol. 15: 319-326

Memorial Sloan Kettering Cancer Centre. Prediction tools, Available at: https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/prediction-tools. Accessed July 11, 2022.

Sabolch A. Feng M. Griffith K. et al.

Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity.

Am J Clin Oncol. 35: 151-157Gronchi A. Lo Vullo S. Colombo C. et al.

Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival.

Ann Surg. 251: 506-511Novais E.N. Demiralp B. Alderete J. et al.

Do surgical margin and local recurrence influence survival in soft tissue sarcomas?.

Clin Orthop Relat Res. 468: 3003-3011Salas S. Stoeckle E. Collin F. et al.

Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.

Eur J Cancer. 45: 2091-2102Sugiura H. Nishida Y. Nakashima H. et al.

Surgical procedures and prognostic factors for local recurrence of soft tissue sarcomas.

J Orthop Sci. 19: 141-149Alamanda V.K. Crosby S.N. Archer K.R. et al.

Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma.

Acta Oncol. 52: 793-802Nakamura T. Grimer R.J. Carter S.R. et al.

Outcome of soft-tissue sarcoma patients who were alive and event-free more than five years after initial treatment.

Bone Joint Lett J. 95-B: 1139-1143Kolovich G.G. Wooldridge A.N. Christy J.M. et al.

A retrospective statistical analysis of high-grade soft tissue sarcomas.

Med Oncol. 29: 1335-1344Binitie O. Tejiram S. Conway S. et al.

Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract.

Clin Orthop Relat Res. 471: 891-898Abatzoglou S. Turcotte R.E. Adoubali A. et al.

Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?.

Clin Orthop Relat Res. 468: 3012-3018Stojadinovic A. Leung D.H.Y. Allen P. et al.

Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.

J Clin Oncol. 20: 4344-4352Cipriano C.A. Jang E. Tyler W.

Sarcoma Surveillance: A Review of Current Evidence and Guidelines.

J Am Acad Orthop Surg. 28: 145-156Toulmonde M. Le Cesne A. Mendiboure J. et al.

Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up.

Cancer. 120: 3003-3006Johnson C.J. Pynsent P.B. Grimer R.J.

Clinical features of soft tissue sarcomas.

Ann R Coll Surg Engl. 83: 203-205

ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors, Available at: https://acsearch.acr.org/docs/69428/Narrative/. Accessed July 20, 2022.

Suspected cancer: recognition and referral NICE Guidance NG12 June 2015, Section 1.11, Available at: http://www.nice.org.uk/guidance/ng12. Accessed July 20, 2022.

Fujiwara T. Grimer R.J. Evans S. et al.

Impact of NICE guidelines on the survival of patients with soft-tissue sarcomas.

Bone Joint Lett J. 103-B: 569-577Gronchi A. Miah A.B. Dei Tos A.P. et al.

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 32: 1348-1365Pohlig F. Kirchhoff C. Lenze U. et al.

Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study.

Eur J Med Res. 17: 29Peer S. Freuis T. Loizides A. et al.

Ultrasound guided core needle biopsy of soft tissue tumors; a fool proof technique?.

Med Ultrason. 13: 187-194De Marchi A. Brach del Prever E.M. Linari A. et al.

Accuracy of core-needle biopsy after contrast-enhanced ultrasound in soft-tissue tumours.

Eur Radiol. 20: 2740-2748Seo S.W. Kwon J.W. Jang S.W. et al.

Feasibility of whole-body MRI for detecting metastatic myxoid liposarcoma: a case series.

Orthopedics. 34: e748-e754King D.M. Hackbarth D.A. Kilian C.M. et al.

Soft-tissue sarcoma metastases identified on abdomen and pelvis CT imaging.

Clin Orthop Relat Res. 467: 2838-2844Portera C.A. Ho V. Patel S.R. et al.

Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.

Cancer. 91: 585-591ESMO/European Sarcoma Network Working Group

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 25: iii102-iii112Kubo T. Furuta T. Johan M.P. et al.

Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.

Eur J Cancer. 58: 104-111Lim H.J. Johnny Ong C.A. Tan J.W.S. et al.

Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: a systematic review.

Crit Rev Oncol Hematol. 143: 1-13

Utility of positron emission tomography in sarcomas.

Curr Opin Oncol. 18: 369-373Eary J.F. O’Sullivan F. Powitan Y. et al.

Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.

Eur J Nucl Med Mol Imaging. 29: 1149-1154Folpe A.L. Lyles R.H. Sprouse J.T. et al.

(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.

Clin Cancer Res. 6: 1279-1287Gerrand C. Athanasou N. Brennan B. et al.On behalf of the British Sarcoma Group

UK guidelines for the management of bone sarcomas.

Clin Sarcoma Res. 6: 7Whooley B.P. Mooney M.M. Gibbs J.F. et al.

Effective follow-up strategies in soft tissue sarcoma.

Semin Surg Oncol. 17: 83-87Whooley B.P. Gibbs J.F. Mooney M.M. et al.

Primary extremity sarcoma: what is the appropriate follow-up?.

Ann Surg Oncol. 7: 9-14

Surveillance strategies for patients following surgical resection of soft tissue sarcomas.

Curr Opin Oncol. 16: 328-332Patel S.R. Zagars G.K. Pisters P.W.T.

The follow-up of adult soft-tissue sarcomas.

Semin Oncol. 30: 413-416Rothermundt C. Whelan J.S. Dileo P. et al.

What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.

Br J Cancer. 110: 2420-2426Lewis J.J. Leung D. Casper E.S. et al.

Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma.

Arch Surg. 134: 190-194Puri A. Gulia A. Hawaldar R. et al.

Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial.

Clin Orthop Relat Res. 472: 1568-1575Puri A. Ranganathan P. Gulia A. et al.

Does a less intensive surveillance protocol affect the survival of patients after treatment of a sarcoma of the limb? updated results of the randomized TOSS study.

Bone Joint Lett J. 100-B: 262-268Patel S.A. Royce T.J. Barysauskas C.M. et al.

Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma.

Ann Surg Oncol. 24: 1588-1595Park J.W. Yoo H.J. Kim H.S. et al.

MRI surveillance for local recurrence in extremity soft tissue sarcoma.

Eur J Surg Oncol. 45: 268-274Kraus D. Oettinger F. Kiefer J. et al.

Efficacy and cost-benefit analysis of magnetic resonance imaging in the follow-up of soft tissue sarcomas of the extremities and trunk.

J Oncol. 2021: 5580431Cheney M.D. Giraud C. Goldberg S.I. et al.

MRI surveillance following treatment of extremity soft tissue sarcoma.

J Surg Oncol. 109: 593-596Aparisi Gómez M.P. Aparisi F. Morganti A.G. et al.

Effects of radiation therapy and chemotherapy on the musculoskeletal system.

Semin Musculoskelet Radiol. 26: 338-353Richardson K. Potter M. Damron T.A.

Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions.

J Surg Oncol. 113: 818-822Labarre D. Aziza R. Filleron T. et al.

Detection of local recurrences of limb soft tissue sarcomas: is magnetic resonance imaging (MRI) relevant?.

Eur J Radiol. 72: 50-53Kransdorf M.J. Murphey M.D.

The use of gadolinium in the MR evaluation of soft tissue tumors.

Semin Ultrasound CT MR. 18: 251-268Chou S.H.S. Hippe D.S. Lee A.Y. et al.

Gadolinium contrast enhancement improves confidence in diagnosing recurrent soft tissue sarcoma by MRI.

Acad Radiol. 24: 615-622Diana Afonso P. Kosinski A.S. Spritzer C.E.

Following unenhanced MRI assessment for local recurrence after surgical resection of mesenchymal soft tissue tumors, do additional gadolinium-enhanced images change reader confidence or diagnosis?.

Eur J Radiol. 82: 806-813Amini B. Murphy W.A. Haygood T.M. et al.

Gadolinium-based contrast agents improve detection of recurrent soft-tissue sarcoma at MRI.

Radiol Imaging Cancer. 2: e190046Soldatos T. Ahlawat S. Montgomery E. et al.

Multiparametric assessment of treatment response in high-grade soft-tissue sarcomas with anatomic and functional MR imaging sequences.

Radiology. 278: 831-840Verstraete K.L. De Deene Y. Roels H. et al.

Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric “first-pass” images depict tissue vascularization and perfusion.

Radiology. 192: 835-843Rimondi E. Benassi M.S. Bazzocchi A. et al.

Translational research in diagnosis and management of soft tissue tumours.

Cancer Imag. 16: 13Del Grande F. Subhawong T. Weber K. et al.

Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T.

Radiology. 271: 499-511Hirschmann A. van Praag V.M. Haas R.L. et al.

Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?.

Eur Radiol. 30: 4724-4733Erber B.M. Reidler P. Goller S.S. et al.

Impact of dynamic contrast enhanced and diffusion-weighted MR imaging on detection of early local recurrence of soft tissue sarcoma.

J Magn Reson Imaging. https://doi.org/10.1002/jmri.28236Aktas E. Arikan S.M. Ardıç F. et al.

The importance of diffusion apparent diffusion coefficient values in the evaluation of soft tissue sarcomas after treatment.

Pol J Radiol. 86: e291-e297Moustafa A.F.I. Eldaly M.M. Zeitoun R. et al.

Is MRI diffusion-weighted imaging a reliable tool for the diagnosis and post-therapeutic follow-up of extremity soft tissue neoplasms?.

Indian J Radiol Imaging. 29: 378-385ElDaly M.M. Moustafa A.F.I. Abdel-Meguid S.M.S. et al.

Can MRI diffusion-weighted imaging identify postoperative residual/recurrent soft-tissue sarcomas?.

Indian J Radiol Imaging. 28: 70-77Maeda M. Matsumine A. Kato H. et al.

Soft-tissue tumors evaluated by line-scan diffusion-weighted imaging: influence of myxoid matrix on the apparent diffusion coefficient.

J Magn Reson Imaging. 25: 1199-1204Noebauer-Huhmann I.M. Chaudhary S.R. Papakonstantinou O. et al.

Soft tissue sarcoma follow-up imaging: strategies to distinguish post-treatment changes from recurrence.

Semin Musculoskelet Radiol. 24: 627-644

Bone and soft tissue tumors: the role of contrast agents for MR imaging.

Eur J Radiol. 34: 229-246Costa F.M. Martins P.H. Canella C. et al.

Multiparametric MR imaging of soft tissue tumors and pseudotumors.

Magn Reson Imaging Clin N Am. 26: 543-558Choi H. Varma D.G. Fornage B.D. et al.

Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery.

AJR Am J Roentgenol. 157: 353-358Pino G. Conzi G.F. Murolo C. et al.

Sonographic evaluation of local recurrences of soft tissue sarcomas.

J Ultrasound Med. 12: 23-26Arya S. Nagarkatti D.G. Dudhat S.B. et al.

Soft tissue sarcomas: ultrasonographic evaluation of local recurrences.

Clin Radiol. 55: 193-197Tagliafico A. Truini M. Spina B. et al.

Follow-up of recurrences of limb soft tissue sarcomas in patients with localized disease: performance of ultrasound.

Eur Radiol. 25: 2764-2770Morel M. Taïeb S. Penel N. et al.

Imaging of the most frequent superficial soft-tissue sarcomas.

Skeletal Radiol. 40: 271-284Hung E.H.Y. Griffith J.F. Ng A.W.H. et al.

Ultrasound of musculoskeletal soft-tissue tumors superficial to the investing fascia.

AJR Am J Roentgenol. 202: W532-W540

Post treatment assessment of soft tissue tumors.

in: DeSchepper A.M. Vanhoenacker F. Gielen J. Imaging of soft tissue tumors. 3rd edition. Springer Verlag, Berlin: 375-381Belli P. Costantini M. Mirk P. et al.

Role of color Doppler sonography in the assessment of musculoskeletal soft tissue masses.

J Ultrasound Med. 19: 823-830Zhao F. Ahlawat S. Farahani S.J. et al.

Can MR imaging be used to predict tumor grade in soft-tissue sarcoma?.

Radiology. 272: 192-201Magarelli N. Carducci C. Bucalo C. et al.

Sonoelastography for qualitative and quantitative evaluation of superficial soft tissue lesions: a feasibility study.

Eur Radiol. 24: 566-573Park H.J. Lee S.Y. Lee S.M. et al.

Strain elastography features of epidermoid tumours in superficial soft tissue: differences from other benign soft-tissue tumours and malignant tumours.

Br J Radiol. 88: 20140797Drakonaki E.E. Allen G.M. Wilson D.J.

Ultrasound elastography for musculoskeletal applications.

Br J Radiol. 85: 1435-1445Taljanovic M.S. Gimber L.H. Becker G.W. et al.

Shear-Wave Elastography: Basic Physics and Musculoskeletal Applications.

Radiographics. 37: 855-870Lee Y.H. Song H.T. Suh J.S.

Use of strain ratio in evaluating superficial soft tissue tumors on ultrasonic elastography.

J Med Ultrason (2001). 41: 319-323Pass B. Johnson M. Hensor E.M.A. et al.

Sonoelastography of musculoskeletal soft tissue masses: a pilot study of quantitative evaluation.

J Ultrasound Med. 35: 2209-2216Pass B. Jafari M. Rowbotham E. et al.

Do quantitative and qualitative shear wave elastography have a role in evaluating musculoskeletal soft tissue masses?.

Eur Radiol. 27: 723-731De Marchi A. Pozza S. Charrier L. et al.

Small Subcutaneous Soft Tissue Tumors (<5 cm) Can Be Sarcomas and Contrast-Enhanced Ultrasound (CEUS) Is Useful to Identify Potentially Malignant Masses.

Int J Environ Res Public Health. 17: E8868De Marchi A. Prever E.B.D. Cavallo F. et al.

Perfusion pattern and time of vascularisation with CEUS increase accuracy in differentiating between benign and malignant tumours in 216 musculoskeletal soft tissue masses.

Eur J Radiol. 84: 142-150Daniels S.P. Mankowski Gettle L. Blankenbaker D.G. et al.

Contrast-enhanced ultrasound-guided musculoskeletal biopsies: our experience and technique.

Skeletal Radiol. 50: 673-681Li A. Peng X.J. Ma Q. et al.

Diagnostic performance of conventional ultrasound and quantitative and qualitative real-time shear wave elastography in musculoskeletal soft tissue tumors.

J Orthop Surg Res. 15: 103Singer G. Cichocki M. Schalamon J. et al.

A study of metatarsal fractures in children.

J Bone Joint Surg Am. 90: 772-776Bignotti B. Rossi F. Signori A. et al.

Magnetic Resonance Imaging or Ultrasound in Localized Intermediate- or High-Risk Soft Tissue Tumors of the Extremities (MUSTT): Final Results of a Prospective Comparative Trial.

Diagnostics. 12: 411Sen J. Agarwal S. Singh S. et al.

Benign vs malignant soft tissue neoplasms: limitations of magnetic resonance imaging.

Indian J Cancer. 47: 280-286Tagliafico A.S. Bignotti B. Rossi F. et al.

Local recurrence of soft tissue sarcoma: a radiomic analysis.

Radiol Oncol. 53: 300-306